Vivencio Barrios

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 24

Top Topics

Atrial Fibrillation

Clinical Practice

Arterial Hypertension

Cardiovascular Events

Top Venues

Journal of clinical medicine

Journal of comparative effectiveness research

Future cardiology

International journal of environmental research and public health

This page only lists publications with an associated author ORCID identifier.

Publications

Fernando Wyss, Vivencio Barrios, Máxima Méndez, Samuel Ramos, Ángel Gonzalez, Héctor Ortiz, Marco Rodas Díaz, Gabriela Castillo, Daniel Quesada, Carlos Enrique Franco, Jaime Ventura, Emilio Peralta López, Francisco Somoza, Ariel Arguello Montealegre, Daniel Meneses, Daniel Pichel, Osiris Valdez
Central American and Caribbean Consensus Document for the Optimal Management of Oral Anticoagulation in Patients with Non-Valvular Atrial Fibrillation Endorsed by the Central American and Caribbean Society of Arterial Hypertension and Cardiovascular Prevention. Journal of clinical medicine 13 (2) (2024)
Fernando Wyss, Vivencio Barrios, Máxima Méndez, Samuel Ramos, Ángel Gonzalez, Héctor Ortiz, Marco Rodas Díaz, Gabriela Castillo, Daniel Quesada, Carlos Enrique Franco, Jaime Ventura, Emilio Peralta López, Francisco Somoza, Ariel Arguello Montealegre, Daniel Meneses, Daniel Pichel, Osiris Valdez
Central American and Caribbean Consensus Document for the Optimal Management of Oral Anticoagulation in Patients with Non-Valvular Atrial Fibrillation Endorsed by the Central American and Caribbean Society of Arterial Hypertension and Cardiovascular Prevention. Journal of clinical medicine 13 (2) (2024)
Pablo Díez-Villanueva, Juan Cosín Sales, Vanessa Roldán Schilling, Vivencio Barrios, Diana Riba-Artés, Olga Gavín-Sebastián, null null
Use of Direct Acting Oral Anticoagulants in Elderly Patients with Atrial Fibrillation: A Multicenter, Cross-Sectional Study in Spain. Journal of clinical medicine 12 (3) (2023)
Francisco Marín, Marcelo Sanmartín Fernández, Gonzalo Barón-Esquivias, Vivencio Barrios, Iñaki Lekuona, Alejandro Isidoro Pérez Cabeza, Jaime Masjuan Vallejo, Esther Recalde Del Vigo, José Manuel Vázquez Rodríguez, Román Freixa-Pamias, Vanessa Roldán Schilling, Fernando Arribas-Ynsaurriaga, Carles Rafols Priu, Manuel Anguita Sánchez
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban. Journal of comparative effectiveness research 12 (3) (2023)
Vicente Pallarés-Carratalá, Vivencio Barrios, David Fierro-González, Jose Polo-García, Sergio Cinza-Sanjurjo
Cardiovascular Risk in Patients with Dyslipidemia and Their Degree of Control as Perceived by Primary Care Physicians in a Survey-TERESA-Opinion Study. International journal of environmental research and public health 20 (3) (2023)
Francisco Marín, Marcelo Sanmartín Fernández, Gonzalo Barón-Esquivias, Vivencio Barrios, Iñaki Lekuona, Alejandro Isidoro Pérez Cabeza, Jaime Masjuan Vallejo, Esther Recalde Del Vigo, José Manuel Vázquez Rodríguez, Román Freixa-Pamias, Vanessa Roldán Schilling, Fernando Arribas-Ynsaurriaga, Carles Rafols Priu, Manuel Anguita Sánchez
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban. Journal of comparative effectiveness research (2023)
Vivencio Barrios, Xavier Pinto, Carlos Escobar, Jose F Varona, José M Gámez
Real-World Attainment of Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Cardiovascular Disease Treated with High-Intensity Statins: The TERESA Study. Journal of clinical medicine 12 (9) (2023)
Vicente Pallarés-Carratalá, Vivencio Barrios, David Fierro-González, Jose Polo-García, Sergio Cinza-Sanjurjo
Cardiovascular Risk in Patients with Dyslipidemia and Their Degree of Control as Perceived by Primary Care Physicians in a Survey-TERESA-Opinion Study. International journal of environmental research and public health 20 (3) (2023)
Carlos González-Juanatey, Manuel Anguita-Sánchez, Vivencio Barrios, Ivan Javier Nuñez-Gil, Juan José Gómez Doblas, Xavier García-Moll, Carlos Lafuente-Gormaz, María Jesús Rollán-Gómez, Vicente Peral-Disdier, Luis Martínez Dolz, Miguel Rodríguez-Santamarta, Xavier Viñolas-Prat, Toni Soriano Colomè, Roberto Muñoz-Aguilera, Ignacio Plaza, Alejandro Curcio-Ruigómez, Ernesto Orts-Soler, Javier Segovia-Cubero, Víctor Fanjul, Judith Marín-Corral, Ángel Cequier, null Savana Research Group
Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain. Journal of clinical medicine 12 (16) (2023)
Mikel Jordhani, Majlinda Cafka, Joana Seiti, Vivencio Barrios
The Relationship between Hyperuricemia and Echocardiographic Parameters in Patients with Chronic Atrial Fibrillation. Journal of clinical medicine 12 (15) (2023)
Pablo Díez-Villanueva, Juan Cosín Sales, Vanessa Roldán Schilling, Vivencio Barrios, Diana Riba-Artés, Olga Gavín-Sebastián, null null
Use of Direct Acting Oral Anticoagulants in Elderly Patients with Atrial Fibrillation: A Multicenter, Cross-Sectional Study in Spain. Journal of clinical medicine 12 (3) (2023)
Francisco Marín, Marcelo Sanmartín Fernández, Gonzalo Barón-Esquivias, Vivencio Barrios, Iñaki Lekuona, Alejandro Isidoro Pérez Cabeza, Jaime Masjuan Vallejo, Esther Recalde Del Vigo, José Manuel Vázquez Rodríguez, Román Freixa-Pamias, Vanessa Roldán Schilling, Fernando Arribas-Ynsaurriaga, Carles Rafols Priu, Manuel Anguita Sánchez
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban. Journal of comparative effectiveness research 12 (3) (2023)
Vicente Pallarés-Carratalá, Antonio Ruiz-García, Adalberto Serrano-Cumplido, Ezequiel Arranz-Martínez, Juan Antonio Divisón-Garrote, Ana Moyá-Amengual, Carlos Escobar, Vivencio Barrios
Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140/90 or 130/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN Study. Medicina (Kaunas, Lithuania) 59 (10) (2023)
Vicente Pallarés-Carratalá, Vivencio Barrios, David Fierro-González, Jose Polo-García, Sergio Cinza-Sanjurjo
Cardiovascular Risk in Patients with Dyslipidemia and Their Degree of Control as Perceived by Primary Care Physicians in a Survey-TERESA-Opinion Study. International journal of environmental research and public health 20 (3) (2023)
Vicente Pallarés-Carratalá, Vivencio Barrios, David Fierro-González, Jose Polo-García, Sergio Cinza-Sanjurjo
Cardiovascular Risk in Patients with Dyslipidemia and Their Degree of Control as Perceived by Primary Care Physicians in a Survey-TERESA-Opinion Study. International journal of environmental research and public health 20 (3) (2023)
Eduardo Zatarain-Nicolás, Pilar Martin, Ivan Marquez-Rodas, Juan Virizuela, Ana Martín García, Cristina Mitroi, Juan Cosín Sales, Vivencio Barrios, Fátima Sánchez-Cabo, Francesco Lavarra, Javier De Castro Carpeño, Teresa López Fernández
Cardiovascular toxicity of checkpoint inhibitors: review of associated toxicity and design of the Spanish Immunotherapy Registry of Cardiovascular Toxicity. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Vivencio Barrios, Xavier Pinto, Carlos Escobar, Jose F Varona, José M Gámez
Real-World Attainment of Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Cardiovascular Disease Treated with High-Intensity Statins: The TERESA Study. Journal of clinical medicine 12 (9) (2023)
Carlos González-Juanatey, Manuel Anguita-Sánchez, Vivencio Barrios, Iván Núñez-Gil, Juan José Gómez Doblas, Xavier García-Moll, Carlos Lafuente-Gormaz, María Jesús Rollán-Gómez, Vicente Peral-Disdier, Luis Martínez-Dolz, Miguel Rodríguez-Santamarta, Xavier Viñolas Prat, Toni Soriano Colomè, Roberto Muñoz-Aguilera, Ignacio Plaza, Alejandro Curcio-Ruigómez, Ernesto Orts-Soler, Javier Segovia, Víctor Fanjul, Miren Taberna, null Savana Research Group
Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing. Journal of clinical medicine 11 (20) (2022)
Vivencio Barrios, Sergio Cinza-Sanjurjo, Javier García-Alegría, Román Freixa-Pamias, Frederic Llordachs-Marques, Carlos A Molina, Amparo Santamaría Ortiz, David Vivas, Carmen Suárez Fernandez
Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach. Future cardiology 18 (9) (2022)
Francisco Marín, Marcelo Sanmartín Fernández, Iñaki Lekuona, Fernando Arribas, Gonzalo Barón-Esquivias, Vivencio Barrios, Juan Cosín Sales, Román Freixa-Pamias, Jaime Masjuan Vallejo, Alejandro Isidoro Pérez Cabeza, Vanessa Roldán Schilling, José Manuel Vázquez Rodríguez, Carles Rafols Priu, Manuel Anguita Sánchez
Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries. Journal of comparative effectiveness research 11 (16) (2022)
Ez Alddin Rajjoub Al-Mahdi, Vivencio Barrios, José Luis Zamorano
Metformin in the era of new antidiabetics. Future cardiology 17 (3) (2021)
Vivencio Barrios, Carlos Escobar
Canagliflozin: metabolic, cardiovascular and renal protection. Future cardiology 17 (3) (2021)
Marcelo Sanmartín Fernández, Francisco Marín, Carles Rafols Priu, Fernando Arribas-Ynsaurriaga, Vivencio Barrios, Juan Cosín Sales, Manuel Anguita Sánchez, null null
Thromboembolic and bleeding events with rivaroxaban in clinical practice in Spain: impact of inappropriate doses (the EMIR study). Journal of comparative effectiveness research 10 (7) (2021)
Vivencio Barrios, Carlos Escobar, Luis Prieto, Jose Polo, Javier Muñiz García, Manuel Anguita, Gregory Y H Lip
A new index to predict quality of anticoagulation control in patients on vitamin K antagonists: the DAFNE score. Future cardiology 17 (4) (2020)